CBSA and the Medtronic Women’s Network are thrilled to present Hannah Gordon, Ph.D., MSCI, Chief Product Officer at Enveda, as the speaker for June’s The Leader Within virtual event

Join us for an inspiring session as Hannah shares her journey of leadership and personal growth.

• See innovation in action: Discover how Enveda identified 10 new chemical entities in just five years — reshaping the future of therapeutics.

• Get inspired by fearless leadership: Gain insights on bold collaboration and scientific rigor from one of biotech’s rising stars.

Dr. Hannah Gordon is a molecular biologist by training and a builder by instinct driving AI-guided, drug discovery as Chief Product Officer at Enveda. She brings over a decade of expertise in translational biology, cutting-edge technologies for drug discovery and commercial acumen. Hannah successfully translates complex scientific concepts into actionable processes, leading cross-functional collaboration to develop first-in-class drug programs sourced from nature.

Enveda is a clinical-stage biotech startup at the forefront transforming drug discovery using AI and metabolomics to decode nature’s chemistry and unlock novel therapeutics at unprecedented speed . Enveda’s platform accelerates drug discovery at 4x the industry pace with 10 wholly owned new chemical entities (NCEs) already nominated in just five years—including a lead asset now in the clinic. The company has earned recognition from Colorado BioScience Association’s Rising Star of the Year in 2022, Endpoints News’ Most Promising Biotech Startups in 2023 to Forbes’ Best Startup Employers and Newsweek’s Greatest Startups in 2025 and most recently Boulder Chamber’s Most Innovative Company.

Before Enveda, Hannah played a pivotal role at Recursion Pharmaceuticals, where she helped launch the company’s first hybrid NCE program and also led AI-driven screening efforts for COVID-19 therapies. Her earlier research spanned multiple genetic model organisms and was published in top-tier publications.

Known for her ability to unify and energize diverse teams, Hannah’s leadership blends scientific rigor with bold curiosity and a collaborative spirit. Her contributions have earned notable honors including being named one of the Top 50 Women Leaders of Utah in 2022. At Enveda, she champions a mindset of fearless innovation and charting new paths.

Hannah holds a Ph.D. in Human Genetics and an M.S. in Clinical Investigation from the University of Utah, where she honed her passion for translating basic science into clinical impact. Outside of work, Hannah opts to be outside, exploring the Rockies with her partner, Tyson, and their dog, Carbon—by foot, bike, ski, and even by air.

Thank you to our event sponsor:

Thank you to our sustaining sponsor: